anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Fusion Pharmaceuticals · pitchdeck

Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides

33 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides

Fusion Pharmaceuticals · 2023-08
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 10 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Solution 3 slides 100% 3/3 slides 100% 3/3 slides · 18 hits
— 0/3 slides
— 0/3 slides
66.7% 2/3 slides 100% 3/3 slides
— 0/3 slides
Market Size 2 slides 100% 2/2 slides 100% 2/2 slides · 14 hits
— 0/2 slides
100% 2/2 slides · 3 hits 50% 1/2 slides 100% 2/2 slides 100% 2/2 slides Product 3 slides 100% 3/3 slides 100% 3/3 slides · 19 hits
— 0/3 slides
— 0/3 slides
33.3% 1/3 slides 100% 3/3 slides
— 0/3 slides
Team 1 slides 100% 1/1 slides 100% 1/1 slides · 12 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

33
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a combination of bulleted benefits and a visual process diagram to explain Targeted Alpha Therapy.argue_timing
Open slide detailBeat · ProblemLoop · Why Now
04
The slide uses a process-oriented layout to highlight vertical integration.present_solution
Open slide detailBeat · Solution
05
The slide uses a Gantt-style visualization to represent clinical trial progress.plan_implementation
Open slide detailBeat · Solution
06
The slide uses a two-column layout to contrast supply partnerships with internal manufacturing infrastructure.present_solution
Open slide detailBeat · Solution
07
Includes a logo grid of past/affiliated companies at the bottom.other
Open slide detailBeat · Team
08
transition
Open slide detail
09
Includes a clinical imaging case study (A-D) showing patient response over time.show_traction
Open slide detailBeat · Market SizeLoop · Quick Win Big Bet
10
Includes specific clinical study citation (Zacherl et al. 2021).show_traction
Open slide detailBeat · Market SizeLoop · Quick Win Big Bet
11
Includes competitive benchmarking context in the footer notes regarding Endocyte and POINT clinical trial data sizes.plan_implementation
Open slide detailBeat · Product
12
The slide illustrates the transition from a 177Lu-based molecule (IPN-1087) to a 225Ac-based molecule (FPI-2059) to improve efficacy.present_solution
Open slide detailBeat · Product
13
The slide outlines a standard 3+3 dose escalation clinical trial design for a radiopharmaceutical.plan_implementation
Open slide detailBeat · Product
14
transition
Open slide detail
15
The slide uses a waterfall plot comparison to contrast clinical outcomes of two different therapeutic modalities.compare_peers
Open slide detail
16
The slide uses a PET scan image to demonstrate selective tumor uptake versus normal tissue, and a table to quantify IGF-1R expression across different cancer typresent_solution
Open slide detail
17
The slide uses a process flow diagram to map out different study arms (Single Ascending Dose, CASS, Multiple Dose Escalation, and Cold/Hot Dosing).plan_implementation
Open slide detail
18
FPI-1434 clinical data presentation.show_traction
Open slide detail
19
The slide outlines two main pillars of the collaboration: targeted alpha therapies and combination therapies.cite_precedent
Open slide detail
20
The slide uses a Y-shaped antibody diagram to illustrate bispecific binding.present_solution
Open slide detail
21
The slide highlights a 'vaccine effect' in 13/15 animals and mentions IP protection for these combinations.present_solution
Open slide detail
22
transition
Open slide detail
23
The slide provides a snapshot of the company's financial health and capital structure.analyze_data
Open slide detail
24
plan_implementation
Open slide detail
25
state_next_steps
Open slide detail
26
appendix
Open slide detail
27
The slide uses medical imaging (SPECT/CT) to visually demonstrate the efficacy of a pharmacological strategy.present_solution
Open slide detail
28
The slide uses two line charts with error bars to demonstrate the therapeutic index improvement of the cold+hot regimen.analyze_data
Open slide detail
29
Includes specific highlighting boxes (green and red) around data columns.analyze_data
Open slide detail
30
Includes SPECT/CT imaging evidence showing increased lesion uptake with the cold/hot regimen.analyze_data
Open slide detail
31
Includes a PET/CT scan image as clinical evidence.show_traction
Open slide detail
32
The slide uses a potency spectrum chart to frame the problem of toxin evolution and a comparison table to highlight the competitive advantages of TATs.present_solution
Open slide detail
33
The slide uses a combination of a biological process diagram and a line chart to demonstrate the competitive advantage of the proprietary linker technology.present_solution
Open slide detail